FGF11 and neoplasm: Additionally, we suggest that targeting the circ_0004851/miR-296-3p/FGF11 axis is a potential strategy for the treatment of PTC, and that circRNA silencing through the ceRNA mechanism could play a crucial therapeutic role in resisting high iodine-promoted tumor progression.